Week 26 results from the PaTH Forward Open-Label Extension Trial Support TransCon PTH as a potential hormone replacement therapy for patients with hypoparathyroidism

Category Primary study
JournalBone Reports
Year 2021
This article has no abstract
Epistemonikos ID: 002dafef2154ee40055ee172be05c93899cb4e67
First added on: Feb 12, 2025